March 02, 2026

FDA Okays Weekly Option in Achondroplasia

Navepegritide is described as the first therapy to deliver continuous C-type natriuretic peptide exposure over a weekly dosing interval in eligible pediatric patients.

Conexiant

February 26, 2026

AHA Issues Pediatric Hypertriglyceridemia Statement

The scientific statement defines pancreatitis and atherosclerotic cardiovascular disease risk thresholds and outlines causes and management in youths.

Conexiant

February 26, 2026

‘You Aren’t Trapped’: Hundreds of US Nurses Choose Canada

American healthcare workers are making a significant move to Canada, driven by political instability in the U.S. and the allure of a progressive health system.

Conexiant

February 25, 2026

AI and Diabetes: Promise and Precaution

The growing ability of AI systems “to influence human biology and lifespan might have implications we are not yet able to grasp."

Conexiant

February 23, 2026

Lifestyle Interventions vs Gestational Diabetes

Investigators report that lifestyle interventions during pregnancy reduce gestational diabetes risk, with effects varying by diagnostic criteria and maternal education level.

Conexiant

February 17, 2026

VA DOD Updates Asthma Framework

The 2025 US Department of Veterans Affairs and US Department of Defense asthma guideline introduces 21 evidence-based recommendations for primary care, redefining stepwise treatment, comorbidity management, and reliever strategy.

Conexiant

February 12, 2026

Ultrasound by Robot: The Debate

State proposes telerobotic scans to address rural gaps.

KFF Health News

February 11, 2026

AMA Backs Structured Vaccine Review

Medical societies and public health groups will collaborate on policy questions and evidence briefs for the 2026 to 2027 respiratory virus season.

Conexiant

February 10, 2026

Youth Obesity Reaches 20% in US

New data from over 6 million children reveal persistent weight disparities across age and racial groups.

Conexiant